30597|t|Intramuscular/oral lorazepam in acute alcohol withdrawal and incipient delirium tremens.
30597|a|An open study was carried out in 21 chronic alcoholics with severe withdrawal symptoms and incipient delirium tremens to evaluate the efficacy of adjuvant treatment with intramuscular lorazepam (5mg). All symptoms subsided within 2 hours after a single injection and remained under control with oral lorazepam (mean daily dose 7 mg). No adverse reactions attributable to lorazepam were observed.
30597	19	28	lorazepam	Chemical	MESH:D008140
30597	38	45	alcohol	Chemical	MESH:D000438
30597	71	87	delirium tremens	Disease	MESH:D000430
30597	133	143	alcoholics	Disease	MESH:D000437
30597	156	175	withdrawal symptoms	Disease	MESH:D013375
30597	190	206	delirium tremens	Disease	MESH:D000430
30597	273	282	lorazepam	Chemical	MESH:D008140
30597	389	398	lorazepam	Chemical	MESH:D008140
30597	460	469	lorazepam	Chemical	MESH:D008140
30597	Negative_Correlation	MESH:D008140	MESH:D000437
30597	Negative_Correlation	MESH:D000438	MESH:D008140
30597	Negative_Correlation	MESH:D008140	MESH:D013375
30597	Negative_Correlation	MESH:D008140	MESH:D000430

